A structure-based mechanism for drug binding by multidrug transporters

Trends in Biochemical Sciences

Volumn 25, Issue 2, 2000, Pages 39-43

  Zheleznova, Ekaterina E ^a   Markham, Penelope ^b   Edgar, Rotem ^c   Bibi, Eitan ^c   Neyfakh, Alexander A ^b   Brennan, Richard G ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; ETHIDIUM BROMIDE; GLYCOPROTEIN P; RHODAMINE 6G; TETRAPHENYLPHOSPHONIUM;

AMINO ACID SEQUENCE; CRYSTAL STRUCTURE; DRUG PROTEIN BINDING; DRUG TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN TERTIARY STRUCTURE; REACTION ANALYSIS; REVIEW; STRUCTURE ANALYSIS; SURFACE CHARGE;

EID: 0033984186     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0004(99)01514-5     Document Type: Note

References (42)

1. Sharom F.J. The P-glycoprotein efflux pump: how does it transport drugs? J. Membr. Biol. 160:1997;161-175.
2. Gottesman M.M., Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62:1993;385-427.
3. Nikaido H. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science. 264:1994;382-388.
4. Paulsen I.T.et al. Proton-dependent multidrug efflux systems. Microbiol. Rev. 60:1996;575-608.
5. Goffeau A.et al. Multidrug-resistant transport proteins in yeast: complete inventory and phylogenetic characterization of yeast open reading frames with the major facilitator superfamily. Yeast. 13:1997;43-54.
6. Fraser C.M.et al. The minimal gene complement of Mycoplasma genitalium. Science. 270:1995;397-403.
7. Roepe P.D. The role of the MDR protein in altered drug translocation across tumor cell membranes. Biochim. Biophys. Acta. 1241:1995;385-405.
8. Bolhuis H.et al. Multidrug resistance in Lactococcus lactis: evidence for ATP-dependent drug extrusion from the inner leaflet of the cytoplasmic membrane. EMBO J. 15:1996;4239-4245.
9. Shapiro A.B.et al. P-glycoprotein-mediated Hoechst 33342 transport out of the lipid bilayer. Eur. J. Biochem. 250:1997;115-121.
10. Higgins C.F., Gottesman M.M. Is the multidrug transporter a flippase? Trends Biochem. Sci. 17:1992;18-21.
11. Tang-Wai D.F.et al. The nitrogen of the acetamido group of colchicine modulates P-glycoprotein-mediated multidrug resistance. Biochemistry. 32:1993;6470-6476.
12. Germann U.A. P-glycoprotein - a mediator of multidrug resistance in tumour cells. Eur. J. Cancer. 32A:1996;927-944.
13. Hanna M.et al. Mutagenesis of transmembrane domain 11 of P-glycoprotein by alanine scanning. Biochemistry. 35:1996;3625-3635.
14. Ahmed M.et al. Mutants of the Bacillus subtilis multidrug transporter Bmr with altered sensitivity to the antihypertensive alkaloid reserpine. J. Biol. Chem. 268:1993;11086-11089.
15. Paulsen I.T.et al. The SMR family: a novel family of multidrug efflux proteins involved with the efflux of lipophilic drugs. Mol. Microbiol. 19:1996;1167-1175.
16. Paulsen I.T.et al. Multidrug resistance proteins QacA and QacB from Staphylococcus aureus: membrane topology and identification of residues involved in substrate specificity. Proc. Natl. Acad. Sci. U. S. A. 93:1996;3630-3635.
17. Klyachko K.A.et al. Mutations affecting substrate specificity of the Bacillus subtilis multidrug transporter Bmr. J. Bacteriol. 179:1997;2189-2193.
18. Edgar R., Bibi E. A single membrane-embedded negative charge is critical for recognizing positively charged drugs by the Escherichia coli multidrug resistance protein MdfA. EMBO J. 18:1999;822-832.
19. Cornwell M.M.et al. Membrane vesicles from multidrug-resistant human cancer cells contain a specific 150- to 170-kDa protein detected by photoaffinity labeling. Proc. Natl. Acad. Sci. U. S. A. 83:1986;3847-3850.
20. Morris D.I.et al. Interaction of forskolin with the P-glycoprotein multidrug transporter. Biochemistry. 30:1991;8371-8379.
21. Bruggemann E.P.et al. Characterization of the azidopine and vinblastine binding site of P-glycoprotein. J. Biol. Chem. 267:1992;21020-21026.
22. Ahmed M.et al. A protein that activates expression of a multidrug efflux transporter upon binding the transporter substrates. J. Biol. Chem. 269:1994;28506-28513.
23. Summers A.O. Untwist and shout: a heavy metal-responsive transcriptional regulator. J. Bacteriol. 174:1992;3097-3101.
24. Markham P.N.et al. Broad ligand specificity of the transcriptional regulator of the Bacillus subtilis multidrug transporter Bmr. Biochem. Biophys. Res. Commun. 239:1997;269-272.
25. Markham P.N.et al. The drug-binding activity of the multidrug-responding transcriptional regulator BmrR resides in its C-terminal domain. J. Bacteriol. 178:1996;473-475.
26. Zheleznova E.E.et al. Structural basis of multidrug recognition by BmrR, a transcription activator of a multidrug transporter. Cell. 96:1999;353-362.
27. Lomovskaya O., Lewis K. Emr, an Escherichia coli locus for multidrug resistance. Proc. Natl. Acad. Sci. U. S. A. 89:1992;8938-8942.
28. Edgar R., Bibi E. MdfA, an Escherichia coli multidrug resistance protein with an extraordinarily broad spectrum of drug recognition. J. Bacteriol. 179:1997;2274-2280.
29. Paulsen I.T., Skurray R.A. Topology, structure and evolution of two families of proteins involved in antibiotic and antiseptic resistance in eukaryotes and prokaryotes - an analysis. Gene. 124:1993;1-11.
30. Yelin R., Schuldiner S. The pharmacological profile of the vesicular monoamine transporter resembles that of multidrug transporters. FEBS Lett. 377:1995;201-207.
31. Ocaktan A.et al. Use of fluorescence probes to monitor function of the subunit proteins of the MexA-MexB-oprM drug extrusion machinery in Pseudomonas aeruginosa. J. Biol. Chem. 272:1997;21964-21969.
32. Mitchell B.A.et al. Bioenergetics of the staphylococcal multidrug export protein QacA. Identification of distinct binding sites for monovalent and divalent cations. J. Biol. Chem. 274:1999;3541-3548.
33. Homolya L.et al. Fluorescent cellular indicators are extruded by the multidrug resistance protein. J. Biol. Chem. 268:1993;21493-21496.
34. Creighton, T.E. (1993) In Proteins (2nd edn), p.156, W.H. Freeman.
35. Romsicki Y., Sharom F.J. The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter. Biochemistry. 38:1999;6887-6896.
36. Dougherty D.A. Cation-pi interactions in chemistry and biology: a new view of benzene, Phe, Tyr, and Trp. Science. 271:1996;163-168.
37. Nilsson I.et al. Proline-induced disruption of a transmembrane alpha-helix in its natural environment. J. Mol. Biol. 284:1998;1165-1175.
38. Finn J.P. III, Edwards R.H. Multiple residues contribute independently to differences in ligand recognition between vesicular monoamine transporters 1 and 2. J. Biol. Chem. 273:1998;3943-3947.
39. Shapiro A.B.et al. Stimulation of P-glycoprotein-mediated drug transport by prazosin and progesterone. Evidence for a third drug-binding site. Eur. J. Biochem. 259:1999;841-850.
40. Loo T.W., Clarke D.M. Membrane topology of a cysteine-less mutant of human P-glycoprotein. J. Biol. Chem. 270:1995;843-848.
41. Beja O., Bibi E. Multidrug resistance protein (Mdr)-alkaline phosphatase hybrids in Escherichia coli suggest a major revision in the topology of the C-terminal half of Mdr. J. Biol. Chem. 270:1995;12351-12354.
42. Cantor, C.R. and Schimmel, P.R. (1980) In Biophysical Chemistry, p.1115, W.H. Freeman.